Applied DNA Sciences (Applied DNA Sciences) Total Current Assets : $4.59 Mil (As of Dec. 2023)

View and export this data going back to 2001. Start your Free Trial

What is Applied DNA Sciences Total Current Assets?

Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. Applied DNA Sciences's total current assets for the quarter that ended in Dec. 2023 was $4.59 Mil.

Applied DNA Sciences Total Current Assets Historical Data

The historical data trend for Applied DNA Sciences's Total Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Applied DNA Sciences Total Current Assets Chart

Applied DNA Sciences Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Total Current Assets

Get a 7-Day Free Trial

2.15

9.08

11.30

19.94

8.13

Applied DNA Sciences Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Current Assets	Get a 7-Day Free Trial															18.33	15.38	12.24	8.13	4.59

Applied DNA Sciences Total Current Assets Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

Applied DNA Sciences's Total Current Assets for the fiscal year that ended in Sep. 2023 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	7.152	+	0.256	+	0.33	+	0.389
	=	8.13

Applied DNA Sciences's Total Current Assets for the quarter that ended in Dec. 2023 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	3.359	+	0.451	+	0.377	+	0.403
	=	4.59

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

Applied DNA Sciences (NAS:APDN) Total Current Assets Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

Applied DNA Sciences's Liquidation Value for the quarter that ended in Dec. 2023 is

	Liquidation value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	3.359	-	5.785	+	0.75 * 0.451	+	0.5 * 0.377
=	-1.90

Applied DNA Sciences Total Current Assets Related Terms

Thank you for viewing the detailed overview of Applied DNA Sciences's Total Current Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Applied DNA Sciences (Applied DNA Sciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Applied DNA Sciences Inc (NAS:APDN) » Definitions » Total Current Assets

Comparable Companies

Traded in Other Exchanges

UDJP:Germany

Address

50 Health Sciences Drive, Stony Brook, New York, NY, USA, 11790

Website

https://www.adnas.com

Applied DNA Sciences Inc is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) nd ribonucleic acid (RNA). The company operates in three business segments- Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. It generates majority of its revenue from the MDx Testing Services which is involved in performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The company provides its products and services under the brand of Applied DNA Sciences, SigNature molecular tags, SigNature T molecular tags, fiberTyping, SigNify and others.

Executives

Clay Shorrock	officer: Chief Legal Officer	C/O APPLIED DNA SCIENCES, INC., 50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790
Scott L Anchin	director	16990 GOLDENTOP ROAD, SUITE A, SAN DIEGO CA 92127
William W Montgomery	10 percent owner	34211 SEAVEY LOOP RD., EUGENE OR 97405
Judith Murrah	officer: Chief Information Officer	C/O APPLIED DNA SCIENCES, INC., 50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790
Beth Jantzen	officer: Chief Financial Officer	C/O APPLIED DNA SCIENCES, INC., 50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790
Yacov A Shamash	director
Robert B Catell	director	62 OSBORNE ROAD, GARDEN CITY NY 11530
John Iii Bitzer	director	C/O APPLIED DNA SCIENCES, INC., 50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790
Joseph D. Ceccoli	director	C/O APPLIED DNA SCIENCES, INC., 50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790
Elizabeth M. Ferguson	director	50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790
Charles S. Ryan	director	C/O APPLIED DNA SCIENCES, INC., 50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790
James A Hayward	director, officer: Chief Executive Officer	C/O 25 HEALTH SCIENCES DRIVE, SUITE 113, NEW YORK NY 11790
Karol Gray	officer: Chief Financial Officer	C/O APPLIED DNA SCIENCES, INC., 50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790
Ming-hwa Benjamin Liang	officer: Strategic Tech. Dev. Officer	C/O APPLIED DNA SCIENCES, INC., 50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790
Yacov Shamash	director	100 ENGINEERING, STATE UNIVERSITY OF NY, STONE BROOK NY 117942200